PIN36 THE IMPACT OF AGE DEPENDENT UTILITY ON THE COST EFFECTIVENESS OF PEGYLATED INTERFERON AND RIBAVIRIN VERSUS INTERFERON AND RIBAVIRIN AS THERAPY FOR GENOTYPE I PATIENTS WITH CHRONIC HEPATITIS C
May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72943-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)72943-0/fulltext
Section Title :
Section Order :
522
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72943-0&doi=10.1016/S1098-3015(10)72943-0